Johnson and Johnson recalls Tylenol as FDA gets tough & Tylenol recall 2010 lot numbers

New York: Johnson and Johnson recalls Tylenol as FDA gets tough & Tylenol recall 2010 lot numbers. Johnson and Johnson is under immense pressure from FDA and consumers over the way it delayed recalling the Tylenol products.

The company had a reputation of not compromising when it came to maintaining highest standards in drug manufacturing and toiletry products.

People are visibly disappointed due to the fact that the company sat for so long without doing anything when complained continued to pour in its offices on the side affects of the Tylenol and some other products.

The U.S. Food and Drug Administration (FDA) again warned Johnson&Johnson (JNJ) unit for its slow pace in recalling Tylenol and other products in response to the heightened number of consumer complaints.

Products like Tylenol, an over-the-counter pain reliever from JNJ had first time received consumer complaints in September 2008. Subsequently, FDA required the company to recall the products and to submit a report.  But, the company did not take any stringent actions, as well failed to make an investigation and to report the issue to the agency on time.

"When something smells bad literally or figuratively companies must aggressively investigate," said Deborah Autor, the director of FDA's Office of Compliance.

She said that the agency dad sent a warning letter to MacNeil Consumer Healthcare, a unit of JNJ that produces Tylenol products for violating agency's manufacturing rules and regulations.

Even earlier on Friday, the company officials said that it was voluntarily taking steps to recall several over-the-counter products, including certain lots of products like Tylenol, Motrin, Benadryl and St. Joseph Aspirin.

Anyhow, it is surprising that what makes the company not to recall products like Tylenol, which the company boasts of having annual sales of more than $1 billion in the U.S.

The FDA warning is said to be occurred as part its vibrant attempts to enforce rules and regulations under the Obama administration. "All drug manufacturers have a corporate responsibility to ensure their products are high quality, safe and effective," Autor said during a press conference. "When a problem arises with their products, they must be proactive, quick and thorough, she added.